TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Investing
3 Things to Look for When Canopy Growth Corp (TSX:WEED) Releases Earnings Next Month

Dividend Stocks
The TSX May Be Off to Its Best Start Since 1980, but These 3 Stocks Continue to Beat the Market
Investing
Here Is What Can Take Canopy Growth (TSX:WEED) Stock to Above $70

Investing
4 Possible Scenarios for Cannabis Stocks in 2019

Investing
Canopy Growth Corp. (TSX:WEED) Is Up Almost 50% in 2019 – Buy or Sell?

Investing
Should You Buy Tilray Inc. (TSX:TLRY) or Canopy Growth Corp (TSX:WEED) Stock?

Investing
Why Canopy Growth (TSX:WEED)(NYSE:CGC) Is Suddenly a Buy
Investing
Canopy Growth Corp’s (TSX:WEED) Big Move Into the U.S.: Why Investors Shouldn’t Get Too Excited
Investing
Canopy Growth Corp (TSX:WEED) Selects a Different U.S. Entry Strategy
Investing
Canopy Growth Corp. (TSX:WEED) Smells Like a Double

Investing
Should TSX Investors Hold Canadian Cannabis Stocks Through a Recession?
